AcousticaBio
PrivateLast Round
Early Funding
Apr 1, 2026
Total Funding Raised
$846,208
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AcousticaBio is a biotechnology company that develops proprietary acoustophoretic technology to enable the formulation and subcutaneous delivery of biologic therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AcousticaBio Comparables
Compare AcousticaBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lindy Biosciences | 87% | |
| Halozyme Therapeutics | 74% | |
| Huons Global Co Ltd | 73% |
AcousticaBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 1, 2026 | ||||
| Grant | Aug 1, 2024 | ||||
| Grant | Aug 1, 2023 | ||||
| Pre Seed | Jan 13, 2022 | ||||
| Grant | Oct 28, 2021 | ||||
Seed | Apr 9, 2021 |
AcousticaBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| NIH RADx | Grant |
| Massachusetts Life Sciences Center | Seed |
| Safar Partners | Seed, Pre Seed |
| MassChallenge Israel | Grant |
| 3CC | Third Culture Capital | Seed, Pre Seed |
| Exor | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 65% MoM, reaching 1.5K.
- Apr 1, 2026
Completed an early funding round.
AcousticaBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AcousticaBio's valuation, stock price, and market status.
Is AcousticaBio a public or private company?
AcousticaBio is a private company.
What is the current stock price of AcousticaBio?
AcousticaBio is a private company with no public stock price. No recent secondary market data is available.
How much is AcousticaBio worth (valuation)?
Valuation information for AcousticaBio is not publicly available.
Can I buy AcousticaBio stock?
AcousticaBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AcousticaBio's last funding round?
AcousticaBio's most recent funding round was Grant on August 1, 2024.
Who are the main investors in AcousticaBio?
Key investors in AcousticaBio include Massachusetts Life Sciences Center.
Will AcousticaBio IPO soon?
No public IPO plans have been announced for AcousticaBio.
How can I track AcousticaBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AcousticaBio's secondary market activity and sign up for updates.